GOLD BOND DIABETICS MEDICATED DRY SKIN RELIEF FOOT CREAM- dimethicone, white petrolatum cream

Gold Bond Diabetics Medicated Dry Skin Relief Foot Cream by

Drug Labeling and Warnings

Gold Bond Diabetics Medicated Dry Skin Relief Foot Cream by is a Otc medication manufactured, distributed, or labeled by Chattem, Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

SPL UNCLASSIFIED SECTION

Drug Facts – Gold Bond Diabetics' Medicated Dry Skin Relief Foot Cream

Active ingredients

Dimethicone 3%
White petrolatum 30%

Purpose

Skin protectant

Uses

• helps relieve, prevent and temporarily protect chafed, chapped or cracked skin 
  
• temporarily protects minor: ■ burns ■ cuts ■ scrapes
  
• helps protect from the drying effects of wind and cold weather

Warnings

For external use only

When using this product

• avoid contact with eyes

Stop use and ask a doctor if

• condition worsens
  
• symptoms persist for more than 7 days or clear up and occur again within a few days

Do not use on

• deep or puncture wounds
  
• animal bites
  
• serious burns

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center immediately.

Directions

• apply generously to affected area as needed

Inactive ingredients

water, glycerin, glyceryl stearate, distearyldimonium chloride, aloe barbadensis leaf juice, polyethylene, stearyl alcohol, cetearyl alcohol, behentrimonium methosulfate, methyl gluceth-20, steareth-2, steareth-21, allantoin, cetyl alcohol, tocopheryl acetate, butyrospermum parkii (shea) butter extract, PEG-10 phytosterol, polysorbate 60, ceramide NG, stearamidopropyl PGdimonium chloride phosphate, jojoba esters, DMDM hydantoin, magnesium ascorbyl phosphate, butylene glycol, methylparaben, palmitoyl hexapeptide-12, propylene glycol, hydrolyzed jojoba esters, propylparaben, EDTA, potassium hydroxide, tribehenin, C12-15 alkyl benzoate, retinyl palmitate

PRINCIPAL DISPLAY PANEL

Gold Bond Diabetics' Medicated Dry Skin Relief Foot Cream
Net wt 3.4 oz (96 g)

INGREDIENTS AND APPEARANCE

GOLD BOND DIABETICS MEDICATED DRY SKIN RELIEF FOOT CREAM 
dimethicone, white petrolatum cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 41167-0541
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
DIMETHICONE (UNII: 92RU3N3Y1O) (DIMETHICONE - UNII:92RU3N3Y1O)	DIMETHICONE	3 g  in 100 g
WHITE PETROLATUM (UNII: B6E5W8RQJ4) (WHITE PETROLATUM - UNII:B6E5W8RQJ4)	WHITE PETROLATUM	30 g  in 100 g

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)
GLYCERIN (UNII: PDC6A3C0OX)
GLYCERYL STEARATE (UNII: 230OU9XXE4)
DISTEARYLDIMONIUM CHLORIDE (UNII: OM9573ZX3X)
ALOE BARBADENSIS LEAF JUICE (UNII: RUE8E6T4NB)
POLYETHYLENE (UNII: UG00KM4WR7)
STEARYL ALCOHOL (UNII: 2KR89I4H1Y)
CETEARYL ALCOHOL (UNII: 2DMT128M1S)
BEHENTRIMONIUM METHOSULFATE (UNII: 5SHP745C61)
METHYL GLUCETH-20 (UNII: J3QD0LD11P)
STEARETH-2 (UNII: V56DFE46J5)
STEARETH-21 (UNII: 53J3F32P58)
ALLANTOIN (UNII: 344S277G0Z)
CETYL ALCOHOL (UNII: 936JST6JCN)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
BUTYROSPERMUM PARKII (SHEA) BUTTER (UNII: K49155WL9Y)
POLYSORBATE 60 (UNII: CAL22UVI4M)
CERAMIDE NG (UNII: C04977SRJ5)
STEARAMIDOPROPYL PG-DIMONIUM CHLORIDE PHOSPHATE (UNII: W6000VEI5Y)
DMDM HYDANTOIN (UNII: BYR0546TOW)
MAGNESIUM ASCORBYL PHOSPHATE (UNII: 0R822556M5)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
METHYLPARABEN (UNII: A2I8C7HI9T)
PALMITOYL HEXAPEPTIDE-12 (UNII: HO4ZT5S86C)
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
HYDROLYZED JOJOBA ESTERS (UNII: UDR641JW8W)
PROPYLPARABEN (UNII: Z8IX2SC1OH)
EDTA (UNII: 9G34HU7RV0)
POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)
TRIBEHENIN (UNII: 8OC9U7TQZ0)
C12-15 ALKYL BENZOATE (UNII: A9EJ3J61HQ)
RETINYL PALMITATE (UNII: 1D1K0N0VVC)
JOJOBA OIL, RANDOMIZED (UNII: 7F0EV20QYL)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 41167-0541-0	1 in 1 CARTON	03/01/2022
1		96 g in 1 TUBE; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M016	03/01/2022

Labeler - Chattem, Inc. (003336013)